Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Wednesday November 11, 2009

DrStockPick.com Stock Report!

**************************************************************

PowerSafe Technology Corporation (PSFT.PK) subsidiary Amplification Technologies Inc. (www.amplificationtechnologies.com) (ATI), is offering higher performance thermoelectrically cooled discrete amplification single photon counting solid state photodetectors. These photodetectors are mounted on a two stage thermoelectric cooler inside a hermetically sealed TO8 package and can be operated down to a temperature of -30oC.

Robin Grey, senior vice president and corporate treasurer for Level 3 Communications, Inc. (NASDAQ: LVLT), will make an investor presentation at the Citi Credit Conference

...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Wednesday October 28, 2009

DrStockPick.com Stock Report!

**************************************************************

Power3 Medical Products, Inc. (OTCBB: PWRM), a leader in neurodegenerative disease and cancer biomarkers and diagnostic tests, announces further international recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf, will deliver an invited Keynote address and chair a session on “Biomarkers and Diagnostics in Personalized Medicine (Track 6-4),” at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, November 19-21, 2009. The Theme of the meeting is “New Leadership of

...

Alexion Pharma (ALXN) is looking for label expansion of its only marketed product Soliris. At present, Soliris is used for treating a chronic disease Paroxysmal Nocturnal Hemoglobinuria (PNH) where red blood cells are destroyed causing severe anemia and blood clots.In an attempt to expand the scope of Soliris for other diseases, ALXN is conducting trials for the treatment of patients with atypical Hemolytic Uremic Syndrome (aHUS) and kidney transplant patients. Estimates put the aHUS market at $400 million to $550 million annually, while the kidney transplant market could be worth $250 million annually.aHUS is a rare disorder in which patients are deficient in normally occurring complement regulatory proteins, leading to chronic inflammation, hemolysis and blood clots, ultimately resulting in kidney failure. The case reports of the patients showed that Soliris reduced hemolysis and platelet consumption, as well as improved kidney function in ...

For Immediate Release

Chicago, IL - April 28, 2009 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Chunghwa Telecom (CHT), Apple, Inc. (AAPL), Omnicom Group, Inc. (OMC), Alexion Pharmaceuticals, Inc. (ALXN) and Moog Inc. (MOG.A).

Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=4579.

Here are highlights from Monday's Analyst Blog:

Chunghwa Outpaces Competition

Chunghwa Telecom (CHT) is the largest integrated telecom operator in Taiwan. Chunghwa commands a significant market share of traditional voice and dial-up services, VoIP, IPTV and broadband in Taiwan.

Aggressive roll-out of fiber-to-the home and 3G network technology,

...

Alexion: One-Drug Wonder Continues - How Long Can This Be Sustained? Soliris sales continues to grow in 1Q09Late last week, Alexion Pharmaceuticals, Inc. (ALXN) reported first quarter 2009 financial results. Soliris sales were in line with our expectation of $81.3 million -- up 78.1% y-o-y and 5% sequentially.Due to strong Soliris sales, Alexion has been enjoying profitability since the second quarter last year. In 1Q09, adjusted net income was $14.6 million, with diluted earnings per share (EPS) of $0.16. Excluding share-based expenses, Alexion achieved a net income of $22.5 million or EPS of $0.25 in 1Q09. First quarter net income and EPS were less than our estimate of $17.6 million and $0.19 per share due to higher R&D and SG&A expenses. Soliris (eculizumab) is a humanized monoclonal antibody complement inhibitor, which blocks cleavage of the C5 component of the complement ...

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Activision Blizzard Inc (ATVI) Aeropostale Inc (ARO) Alexion Pharmaceuticals Inc (ALXN) Basilea Pharmaceutic (BPMUF) BCE Inc (BCE) China Pharma Holdings Inc (CPHI) Comscore Inc (SCOR) DRDGold Ltd (DROOY) EnteroMedics Inc (ETRM) Fidelity National Information Services (FIS) Grand Canyon Education Inc (LOPE) Green Mountain Coffee Roasters Inc (GMCR) Haemonetics Corp (HAE) Hana Biosciences Inc (HNAB) Healthcare Services Group Inc (HCSG) Hecla Mining Co (HL) Merck & Co Inc (MRK) Omnova Solutions Inc (OMN) OSI Systems Inc (OSIS) Radio One Inc (ROIAK) Randgold Resources Ltd (GOLD) Ross Stores Inc (ROST) SupportSoft Inc (SPRT) Tecumseh Products Co (TECUA) Tier Technologies Inc (TIER) Tortoise Capital Resources Corp (TTO) Vertex Pharmaceuticals Inc (VRTX) ...

Alexion Pharmaceuticals Inc. (ALXN) broke through a long-term level of resistance at $37.49 on Tuesday. The Zacks #1 Rank (“Strong buy”) stock has topped the consensus estimate is all of the last 4 quarters.

"ALXN" Free Stock Analysis: Buy? Sell? Hold?Zacks Investment Research

Here are the stocks added to the Zacks #1 Rank ("strong buy") List today:

Ajinomoto Co Inc (AJINY) Alexza Pharmaceuticals Inc (ALXA) Alexion Pharmaceuticals Inc (ALXN) Amerisafe Inc (AMSF) APAC Customer Services Inc (APAC) Atmos Energy Corp (ATO) Bio-Reference Laboratories Inc (BRLI) Command Security Corp (MOC) Conmed Healthcare Management Inc (CMHM) Conseco Inc (CNO) Discovery Communications Inc (DISCB) Flanders Corp (FLDR) Gerdau SA (GGB) I-Many Inc (IMNY) Investors Bancorp Inc (ISBC) Jackson Hewitt Tax Service Inc (JTX) James Hardie Industries NV (JHX) Kaman Corp (KAMN) Labopharm Inc (DDSS) Mag Silver Corp (MVG) Metabasis Therapeutics Inc (MBRX) National Beverage Corp (FIZZ) NCI Inc (NCIT) Neogen Corp (NEOG) NeuroMetrix Inc (NURO) Nova Biosource Fuels Inc (NBF) Palatin Technologies Inc (PTN) Pegasystems Inc (PEGA) ...